Institutions / Commodore Capital LP
Commodore Capital LP
CIK 1831942 · Institution · as of Dec 31, 2025
Portfolio value
$1.50B
Positions
33
As of
Dec 31, 2025
Top holdings
Dec 31, 2025View all 33 →
| Company | Value | % of portfolio |
|---|---|---|
| Relay Therapeutics, Inc. | $143.82M | 9.6% |
| Alkermes plc. | $99.33M | 6.6% |
| Tyra Biosciences, Inc. | $88.73M | 5.9% |
| Xenon Pharmaceuticals Inc. | $80.68M | 5.4% |
| Spyre Therapeutics, Inc. | $78.24M | 5.2% |
| Cogent Biosciences, Inc. | $78.03M | 5.2% |
| Enliven Therapeutics, Inc.ELVN | $72.27M | 4.8% |
| Celldex Therapeutics, Inc. | $69.67M | 4.6% |
| Amylyx Pharmaceuticals, Inc. | $68.25M | 4.5% |
| Terns Pharmaceuticals, Inc. | $59.59M | 4.0% |
| Kymera Therapeutics, Inc. | $58.36M | 3.9% |
| Soleno Therapeutics, Inc. | $55.56M | 3.7% |
| Nuvalent, Inc. | $55.32M | 3.7% |
| Oruka Therapeutics, Inc. | $53.14M | 3.5% |
| Pharvaris N.V. | $52.43M | 3.5% |
| Nurix Therapeutics, Inc. | $43.16M | 2.9% |
| Protagonist Therapeutics Inc | $39.30M | 2.6% |
| Assembly Biosciences, Inc.ASMB | $34.01M | 2.3% |
| Lb Pharmaceuticals IncLBRX | $33.39M | 2.2% |
| CytomX Therapeutics, Inc. | $32.77M | 2.2% |
| Alto Neuroscience, Inc.ANRO | $32.45M | 2.2% |
| Palisade Bio, Inc. | $26.90M | 1.8% |
| Mind Medicine Mindmed Inc | $26.78M | 1.8% |
| Centessa Pharmaceuticals PLC | $25.01M | 1.7% |
| PepGen Inc. | $22.13M | 1.5% |
Activity
Dec 31, 2025
InsidersInstitutions
This fund's 13F position changes — what it's buying and selling.No quarter-over-quarter changes yet — position changes appear once we've ingested two consecutive 13F filings for this manager. We currently hold 1 quarter of holdings.